Mortality at maximal · people with early‐ or very early‐stage hepatocellular carcinoma ineligible for surgery
It is very uncertain whether laser ablation changes mortality at maximal compared with radiofrequency ablation (very low certainty).
1 finding from 1 review
Cancer‐related mortality at maximal · people with early‐ or very early‐stage hepatocellular carcinoma ineligible for surgery
It is very uncertain whether laser ablation changes cancer‐related mortality at maximal compared with radiofrequency ablation (very low certainty).
1 finding from 1 review
Serious adverse events (number of participants) · people with early‐ or very early‐stage hepatocellular carcinoma ineligible for surgery
It is very uncertain whether laser ablation changes serious adverse events (number of participants) compared with radiofrequency ablation (very low certainty).
1 finding from 1 review
Serious adverse events (number of events) · people with early‐ or very early‐stage hepatocellular carcinoma ineligible for surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life · people with early‐ or very early‐stage hepatocellular carcinoma ineligible for surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Recanalisation or persistence of reflux at 6 weeks · people requiring intervention for short saphenous vein varices
Endovenous laser ablation probably leads to lower recanalisation or persistence of reflux at 6 weeks compared with conventional surgery (moderate certainty).
1 finding from 1 review
Recurrence of reflux at 1 year · people requiring intervention for short saphenous vein varices
Endovenous laser ablation may leads to lower recurrence of reflux at 1 year compared with conventional surgery (low certainty).
1 finding from 1 review
Recurrence · people requiring intervention for short saphenous vein varices
Endovenous laser ablation showed no clear difference in clinical evidence of recurrence after 1 year compared with conventional surgery (low certainty).
1 finding from 1 review
Reintervention (due to technical failure) · people requiring intervention for short saphenous vein varices
1 finding from 1 review
Disease‐specific quality of life · people requiring intervention for short saphenous vein varices
2 findings from 1 review
Complications at 6 weeks · people requiring intervention for short saphenous vein varices
1 finding from 1 review
Technical success · people with GSV incompetence
Endovenous laser ablation (EVLA) showed no clear difference in technical success (< 5 years) compared with radiofrequency ablation (RFA) (moderate certainty).
2 findings from 1 review
Recurrence · people with GSV incompetence
Endovenous laser ablation (EVLA) showed no clear difference in recurrence (< 5 years) compared with radiofrequency ablation (RFA) (low certainty).
1 finding from 1 review
Long‐term recurrence (> 5 years) · people with GSV incompetence
Endovenous laser ablation (EVLA) may leads to higher long‐term recurrence (> 5 years) compared with radiofrequency ablation (RFA) (low certainty).
1 finding from 1 review
Complications (up to 8 years) · people with GSV incompetence
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
QoL · people with GSV incompetence
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Long‐term recurrence (> 5 years) · people with GSV incompetence
It is very uncertain whether endovenous laser ablation (EVLA) changes long‐term recurrence (> 5 years) compared with ultrasound‐guided foam sclerotherapy (UGFS) (very low certainty).
1 finding from 1 review
Complications (up to 8 years) · people with GSV incompetence
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
QoL · people with GSV incompetence
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Technical success · people with GSV incompetence
Endovenous laser ablation (EVLA) may leads to higher technical success (< 5 years) compared with SFJ ligation and stripping (HL/S) (low certainty).
2 findings from 1 review